A Study of Bimatoprost 0.01% in the Clinical Setting

Trial Profile

A Study of Bimatoprost 0.01% in the Clinical Setting

Phase of Trial: Phase IV

Latest Information Update: 29 Oct 2015

At a glance

  • Drugs Bimatoprost (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Acronyms APPEAL-Taiwan
  • Sponsors Allergan
  • Most Recent Events

    • 21 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top